Serum xenopsin-related peptide-1 levels in pregnant women with hyperemesis gravidarum; a cross-sectional study
Open Access
- 8 January 2026
- journal article
- research article
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 26 (1)
Abstract
To investigate serum xenopsin-related peptide (XRP) -1 levels in women with hyperemesis gravidarum (HEG) from the onset of pregnancy until the end of weekKeywords
This publication has 22 references indexed in Scilit:
- Platelet to Lymphocyte Ratio and Neutrophil to Lymphocyte Ratio in Missed AbortionRevista Brasileira de Ginecologia e Obstetrícia, 2020
- Predictive factors of Hyperemesis Gravidarum: A systematic reviewEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2019
- Hyperemesis gravidarum and adverse pregnancy outcomesArchives of Gynecology and Obstetrics, 2019
- Neutrophil-Lymphocyte ratio and Platelet-Lymphocyte ratio as useful predictive markers of prediabetes and diabetes mellitusDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2017
- Elevated circulating levels of xenopsin-related peptide-1 are associated with polycystic ovary syndromeArchives of Gynecology and Obstetrics, 2017
- Treatments for Hyperemesis Gravidarum and Nausea and Vomiting in PregnancyJAMA, 2016
- Adjusted leptin level (ALL) is a predictor for hyperemesis gravidarumEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2006
- Xenopsin-related peptide generated in avian gastric extractsRegulatory Peptides, 1988
- Generation of xenopsin-related peptides during acid extraction of gastric tissues.Journal of Biological Chemistry, 1985
- The Effects of Xenopsin on Endocrine Pancreas and Gastric Antrum in DogsHormone and Metabolic Research, 1978